Lisata Therapeutics LSTA
NASDAQ LSTA
$1.43 -0.04 (-2.38%)
As of: Sep 30, 2026 · 9:32 AM EDT

Lisata Therapeutics (LSTA) FCF Margin (2010 - 2025)

Updated

Lisata Therapeutics' FCF Margin was -2499.23% in Q4 2025, down 2046.43 percentage points from -452.80% a year earlier.

Analysis

Lisata Therapeutics (LSTA) FCF Margin (2010 - 2025) Analysis & Trends

For FY2025, FCF Margin at Lisata Therapeutics came in at -7988.50%, down 6052.90 percentage points from FY2024.

  • In earlier years, FCF Margin was -1935.60% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Lisata Therapeutics 13.68 Mn 13.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,499.23%
Jun 30, 2025 -5,651.43%
Dec 31, 2024 -452.80%
Mar 31, 2017 -128.21%
Dec 31, 2016 -52.63%
Sep 30, 2016 -61.42%
Jun 30, 2016 -110.51%
Mar 31, 2016 -121.14%
Dec 31, 2015 -123,540.49%
Sep 30, 2015 -160.90%
Jun 30, 2015 -154.17%
Mar 31, 2015 -459.76%
Dec 31, 2014 -220,535.08%
Sep 30, 2014 -339,282.49%
Jun 30, 2014 -277,397.19%
Mar 31, 2014 -308,016.42%
Dec 31, 2013 -223,315.87%
Sep 30, 2013 -196,709.98%
Jun 30, 2013 -142,349.16%
Mar 31, 2013 -284,837.72%
API Access

Lisata Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=LSTA&period=max&api_key=YOUR_API_KEY